Status™ COVID-19/Flu A&B Antigen Rapid Test
Status™ COVID-19/Flu A&B Antigen Rapid Test
description
As of October 27, 2021 the StatusTM COVID-19/Flu A&B is now authorized for use with anterior nasal swab specimens as well as nasopharyngeal swab specimens.
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from nasopharyngeal swab specimens
- FDA Emergency Use Authorization (EUA)
- Visually read in 15 minutes
- Flocked nasopharyngeal swab for superior specimen collection and patient comfort
Sensitivity and Specificity
- COVID-19 - Sensitivity 93.9%, Specificity 100%
- Flu A - Sensitivity 91.4%, Specificity 95.7%
- Flu B - Sensitivity 87.6%, Specificity 95.9%
CPT CODES: COVID-19: 87811
FLU A: 87804QW
FLU B: 87804QW-59
Product Attachments
Expiration Dating Memo
Status™ COVID-19/Flu Package Insert
Status™ COVID-19/Flu SDS
Status™ COVID-19/Flu CLSI
Status™ COVID-19/Flu Provider Fact Sheet
Status™ COVID-19/Flu Patient Fact Sheet
Status™ COVID-19/Flu Procedure Card
Status™ COVID-19/Flu Sell Sheet